Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 20 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2003The expression of 25-hydroxyvitaminD 24-hydroxylase and 25-hydroxyvitaminD 1 alpha-hydroxylase in human osteoblasts.Anderson, P.; Atkins, G.; Morris, H.; Kostakis, P.; Findlay, D.; Zannettino, A.; European Symposium on Calcified Tissues (30th : 2003 : Rome, Italy)
2003The expression of 25-hydroxyvitaminD 24-hydroxylase and 25-hydroxyvitaminD 1 alpha-hydroxylase in human osteoblastsAtkins, G.; Anderson, P.; Morris, H.; Zannettino, A.; Kostakis, P.; Findlay, D.; Annual Meeting of the American Society for Bone and Mineral Research (25th : 2003 : Minnesota, USA )
2011Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivoZinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2003The relationship between RANKL expression and osteoblast differentiation in human osteoblastsKostakis, P.; Atkins, G.; Pan, B.; Farrugia, A.; Gronthos, S.; Evdokiou, A.; Findlay, D.; Zannettino, A.; European Symposium on Calcified Tissues (30th : 2003 : Rome, Italy)
2006Evidence for reduced bone formation surface relative to bone resorption surface in female femoral fragility fracture patientsTsangari, H.; Findlay, D.; Zannettino, A.; Pan, B.; Kuliwaba, J.; Fazzalari, N.
2007Metabolism of vitamin D₃ in human osteoblasts: Evidence for autocrine and paracrine activities of 1α,25-dihydroxyvitamin D₃Atkins, G.; Anderson, P.; Findlay, D.; Welldon, K.; Vincent, C.; Zannettino, A.; O'Loughlin, P.; Morris, H.
2002Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosisAtkins, G.; Bouralexis, S.; Evdokiou, A.; Hay, S.; Labrinidis, A.; Zannettino, A.; Haynes, D.; Findlay, D.
2008Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?Labrinidis, A.; Liapis, V.; Thai, L.; Atkins, G.; Vincent, C.; Hay, S.; Sims, N.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2009Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancerZinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Zannettino, A.; Findlay, D.; Evdokiou, A.
2009Apo2L/TRAIL inhibits tumor growth and bone destruction in a murine model of multiple myelomaLabrinidis, A.; Diamond, P.; Martin, S.; Hay, S.; Liapis, V.; Zinonos, I.; Sims, N.; Atkins, G.; Vincent, C.; Ponomarev, V.; Findlay, D.; Zannettino, A.; Evdokiou, A.